Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Spinal Implants by Quarter
Spinal Implants (Reflects May 2025 U.S. Spinal Implants Divestiture to VB Spine) — International Net Sales ($M) ($M)
Stryker Spinal Implants: $4M in Q3 2026, down 33.3% from a year earlier.
Latest, Q3 2026
4
Period ended Sep 30, 2026
Change on a year earlier
-33.3%
6 in Q3 2025
History
21 quarters
Since Q1 2021
Sources
7
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Schedules, Recast 8-K & Form 10-K/10-Q Note 15.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up spinal Implants
Cite this data
StockData. (2026). Stryker Spinal Implants ($M), quarterly Q1 2021–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-spine-intl-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.